NCT04942301 2021-06-30
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown
Jiangsu Simcere Pharmaceutical Co., Ltd.
University of Wisconsin, Madison
National Cancer Institute (NCI)
Fudan University
Dana-Farber Cancer Institute
Sun Yat-sen University